BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 44,200 Value ($000) $112 Avg Close — Range —
Q2 2023
Shares 44,200 Value ($000) $294 Avg Close — Range —
Q1 2023
Shares 42,300 Value ($000) $789 Avg Close — Range —
Q4 2022
Shares 46,300 Value ($000) $995 Avg Close — Range —
Q3 2022
Shares 46,300 Value ($000) $547 Avg Close — Range —
Q2 2022
Shares 46,300 Value ($000) $611 Avg Close — Range —
Q1 2022
Shares 46,300 Value ($000) $968 Avg Close — Range —
Q4 2021
Shares 42,400 Value ($000) $862 Avg Close — Range —
Q3 2021
Shares 42,400 Value ($000) $1,287 Avg Close — Range —
Q2 2021
Shares 42,400 Value ($000) $1,232 Avg Close — Range —
Q1 2021
Shares 33,400 Value ($000) $1,442 Avg Close — Range —
Q4 2020
Shares 30,300 Value ($000) $1,400 Avg Close — Range —
Q3 2020
Shares 33,600 Value ($000) $1,457 Avg Close — Range —
Q2 2020
Shares 22,600 Value ($000) $1,198 Avg Close — Range —